MedPath

Effect of permethrin 5% cream versus metronidazole 0.75% gel on skin region in patients with papulopustular rosacea

Phase 2
Completed
Conditions
Papulopustular rosacea.
Rosacea
Registration Number
IRCT201508169014N75
Lead Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

affected with papulopustular rosacea.
Exclusion criteria: mild rosacea stage 1 with mild erythema without lesions; presence of ocular signs or symptoms; steroidal rosacea; previous history of sensitivity to permethrin or metronidazole; breastfeeding.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.